AI Science Tracker
EN

Identification of SARS-CoV-2-specific T cell and its receptor

Clinical Research Institute, The First Affiliated Hospital of Xiamen University, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Medicine, Xiamen University, Xiamen, China; Clinical Research Institute, The First Affiliated Hospital of Xiamen University, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Medicine, Xiamen University, Xiamen, China; Department of Emergency Medicine, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China; Clinical Research Institute, The First Affiliated Hospital of Xiamen University, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Medicine, Xiamen University, Xiamen, China; National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, China; Shanghai Engineering Research Center of Intelligent Education and Bigdata, Shanghai Normal University, Shanghai, China; Clinical Research Institute, The First Affiliated Hospital of Xiamen University, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Medicine, Xiamen University, Xiamen, China · 27 Mar 2024 · medicine

Discovery

Identification of SARS-CoV-2-specific T cell and its receptor

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: AI-supported repertoire analysis is linked to specific SARS-CoV-2 T-cell/TCR identification that is experimentally followed up. Specificity and cytotoxicity evidence is in defined assays/animal models, not clinical efficacy.

Technology: ML classifier based on TCR sequence features distinguishes COVID patients and healthy controls (95.7% accuracy); peptide stimulation in HLA-A*02 vaccinated individuals identifies SARS-CoV-2-specific T cells/TCRs, with cloned TCR functional assays and mouse intranasal peptide immunization showing T-cell responses. Findings include specific TCR/epitope response. Distinguish human ex-vivo, in-vitro and mouse evidence; no human vaccine efficacy claim

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
ML classifier based on TCR sequence features distinguishes COVID patients and healthy controls (95.7% accuracy); peptide stimulation in HLA-A*02 vaccinated individuals identifies SARS-CoV-2-specific T cells/TCRs, with cloned TCR functional assays and mouse intranasal peptide immunization showing T-cell responses. Findings include specific TCR/epitope response. Distinguish human ex-vivo, in-vitro and mouse evidence; no human vaccine efficacy claim
Limitation / still unknown
The result is limited to the reported dataset, experimental setting and validation in this study; broader generalization and real-world benefit are not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1186/s13045-024-01537-6

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.